Do you look close enough?

The micro view of your reputation

Advanced media analytics and consultancy that gives your reputation the strategic edge

Look closer

Are you ready for the age of reputation?

Corporate communication challenges in the reputation age require strategic media intelligence. That’s what we do.

PR & COMMS

For professionals who need to really understand the attitudes and views of their audience.

MARKETING

Unlock the potential of your brand through the power of analytics.

IR & RISK

A new business intelligence framework to manage reputation and shareholder value.

CEO & EXECUTIVES

C-level ready insight on communications campaigns outcomes related to key business objectives.

Not all our intelligence is artificial.

AI-enabled human insight sets us apart.

Our expertise

Featured insights

CEOs Reaction to Biden: The Dawn of CEO Activism?

There’s no question the 2020 US election was unusual in every way. But there was one particular aspect which was especially interesting to corporate comms professionals: CEOs played an important role during one of the most turbulent times in recent American history.

Many business leaders engaged in CEO political activism early on – even those who normally try to stay away from politics. For instance, on Nov. 6, more than two dozen CEOs of major corporations took part in a video conference to discuss what to do if Trump refuses to leave office or takes other steps to stay in power.

AstraZeneca: Corporate Reputation Analysis Case Study

Managing corporate reputation has turned into a strategic business objective for many companies, posing serious challenges to PR and comms teams to measure and manage reputation in real-time as standard media listening and analytics solutions are not tailored for reputation monitoring.

The analysis is based on 1,979,257 English-language articles from more than 15,000 online media outlets, published in the period 1st January 2019-31st December 2020.

Biotech: Pharma’s Reputation Saviour?

Our recent pharma analysis concluded that journalists have started to report more favourably of pharma’s work and that companies are experiencing a reputational boost as the pandemic highlights their role in developing medications and vaccines.

This comes at a time when 40% of Americans have a more positive view of the pharma industry than they did before the pandemic began, according to the latest Harris Poll survey. Moreover, data-intelligence company Morning Consult found that the pharmaceutical industry’s net favorability increased this year to 17% from 13% (net favourability is defined as the share of people with a favourable impression minus those with an unfavourable impression).

The 10/90 rule for media analytics

For every dollar invested in media analytics tools, nine times as much should be invested in human interpretation and analysis. We create collaborative intelligence by combining technology and expert human insight to enable our clients realise the full potential of their media research investments.

Learn more

Genuine technology

We use ‘AI’ not only in presentations

Companies increasingly invoke AI in their marketing regardless of their true expertise in the area. We have invested more than 250 man years of expertise to create a unique technology platform, a hybrid between rule-based NLP and machine learning.

Learn More

Genuine technology

We use ‘AI’ not only in presentations

Companies increasingly invoke AI in their marketing regardless of their true expertise in the area. We have invested more than 250 man years of expertise to create a unique technology platform, a hybrid between rule-based NLP and machine learning.

Learn More